[Clinical efficacy of switching to tenofovir amibufenamide tablets with poor response to entecavir in patients with chronic hepatitis B].
Year: 2024
Type: other
Abstract: Switching to tenofovir amibufenamide tablets can improve liver function and promote HBV DNA negative conversion with poor response to entecavir in patients with chronic hepatitis B, with better therapeutic effect in HBeAg-negative patients.
Source: PubMed
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4407800637